Ajax-Loading

AbbVie Inc - Price Earnings Ratio

AbbVie Inc's Fiscal Year is From January To December.

The item "Price-Earnings-Ratio" stands at 158.00 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Price Earnings Ratio" stands at 158.00. This represents an increase of 90.74 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 148.08 percent compared to the value the year prior.
The 1 year change in percent is 148.08.
The 3 year change in percent is 788.48.

The Serie's long term average value is 52.63. It's latest available value, on 09/30/2025, is 200.24 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +788.48%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Price Earnings Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price Earnings Ratio905,699,262,464.00
LogoJohnson & Johnson - Price Earnings Ratio486,508,953,600.00
LogoRoche Holding AG - Price Earnings Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price Earnings Ratio280,205,508,085.11
LogoNovartis AG - Price Earnings Ratio255,096,620,580.91